Related Experiment Video
Updated: Apr 25, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Early histopathological changes in new-onset diabetes after kidney transplantation
B Borda1, Y Munir Ibrahim1, C Lengyel2
1Department of Surgery, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Background:
New-onset diabetes after transplantation (NODAT) is one of the most common complications after kidney transplantation.
Methods:
Patients were randomly assigned to receive cyclosporine A-based or tacrolimus-based immunosuppression. Fasting and oral glucose tolerance tests were performed, and the patients were assigned to one of the following 3 groups, on the basis of the results: normal, impaired fasting glucose/impaired glucose tolerance, or NODAT. NODAT developed in 14% of patients receiving cyclosporine A-based immunosuppression and in 26% of patients taking tacrolimus (P = .0002).
Results:
Albumin levels were similar, but uric acid level (P = .002) and the age of the recipient (P = .003) were significantly different between the diabetic and the normal groups. Evaluation of tissue samples revealed that acute cellular rejection and interstitial fibrosis/tubular atrophy were significantly different in the NODAT group. Changes in the Banff score provided significant difference regarding tubulitis and interstitial inflammation (P = .05).
Conclusions:
The pathological effect of new-onset diabetes after kidney transplantation can be detected in the morphology of the renal allograft earlier, before the development of any sign of functional impairment.
Insights
New-onset diabetes after transplantation (NODAT) is common after kidney transplants. Tacrolimus-based immunosuppression increased NODAT risk compared to cyclosporine A, with early pathological changes in the renal allograft observed.
Area of Science:
- Nephrology
- Transplantation Immunology
- Endocrinology
Background:
- New-onset diabetes after transplantation (NODAT) is a frequent complication following kidney transplant procedures.
- Understanding the risk factors and early indicators of NODAT is crucial for patient outcomes.
Purpose of the Study:
- To compare the incidence of NODAT between cyclosporine A-based and tacrolimus-based immunosuppression regimens.
- To identify early pathological changes in renal allografts associated with NODAT.
Main Methods:
- Randomized assignment of patients to cyclosporine A or tacrolimus immunosuppression.
- Performance of fasting and oral glucose tolerance tests to diagnose diabetes status.
- Analysis of renal allograft biopsies using Banff scoring for rejection and fibrosis.
Main Results:
- NODAT incidence was significantly higher with tacrolimus (26%) compared to cyclosporine A (14%).
- Elevated uric acid levels and recipient age were associated with NODAT development.
- Renal allografts in the NODAT group showed increased acute cellular rejection and interstitial fibrosis/tubular atrophy.
Conclusions:
- Pathological changes in renal allografts can precede functional impairment in NODAT.
- Immunosuppression choice significantly impacts NODAT risk.
- Early detection of allograft pathology may aid in managing NODAT.
Related Concept Videos
Diabetic Nephropathy
Kidney Transplant I: Introduction
Diabetic Retinopathy
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Type I Diabetes III: Clinical Manifestations

